Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection

GBS hemolytic lipid/pigment and hyperpigmented GBS activate mast cells triggering the release of preformed and proinflammatory mediators. Ascending infection of microbes from the lower genital tract into the amniotic cavity increases the risk of preterm birth, stillbirth, and newborn infections. Host defenses that are critical for preventing ascending microbial infection are not completely understood. Group B Streptococcus (GBS) are Gram-positive bacteria that frequently colonize the lower genital tract of healthy women but cause severe infections during pregnancy, leading to preterm birth, stillbirth, or early-onset newborn infections. We recently described that the GBS pigment is hemolytic, and increased pigment expression promotes GBS penetration of human placenta. Here, we show that the GBS hemolytic pigment/lipid toxin and hyperpigmented GBS strains induce mast cell degranulation, leading to the release of preformed and proinflammatory mediators. Mast cell–deficient mice exhibit enhanced bacterial burden, decreased neutrophil mobilization, and decreased immune responses during systemic GBS infection. In a vaginal colonization model, hyperpigmented GBS strains showed increased persistence in mast cell–deficient mice compared to mast cell–proficient mice. Consistent with these observations, fewer rectovaginal GBS isolates from women in their third trimester of pregnancy were hyperpigmented/hyperhemolytic. Our work represents the first example of a bacterial hemolytic lipid that induces mast cell degranulation and emphasizes the role of mast cells in limiting genital colonization by hyperpigmented GBS.

[1]  M. Deeble,et al.  EDITORIAL AND PRODUCTION STAFF , 2017, Russian-English Dictionary of Idioms.

[2]  S. Lebeer,et al.  Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health , 2015, Front. Physiol..

[3]  Claire Gendrin,et al.  A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury , 2015, EMBO molecular medicine.

[4]  H. Tettelin,et al.  Complete Genome Sequence of Streptococcus agalactiae CNCTC 10/84, a Hypervirulent Sequence Type 26 Strain , 2014, Genome Announcements.

[5]  T. van der Poll,et al.  Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia. , 2014, The Journal of infectious diseases.

[6]  J. Davoust,et al.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. , 2014, The Journal of clinical investigation.

[7]  Jeffrey Dach,et al.  Jeffrey Dach, MD: the transition to a natural medicine practice. , 2014, Alternative therapies in health and medicine.

[8]  G. Pejler,et al.  Mast cell secretory granules: armed for battle , 2014, Nature Reviews Immunology.

[9]  B. Monks,et al.  RNA and β-Hemolysin of Group B Streptococcus Induce Interleukin-1β (IL-1β) by Activating NLRP3 Inflammasomes in Mouse Macrophages* , 2014, The Journal of Biological Chemistry.

[10]  J. Wijgert,et al.  Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women , 2014, The ISME Journal.

[11]  V. Nizet,et al.  Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. , 2014, The Journal of infectious diseases.

[12]  K. Cease,et al.  Staphylococcus δ-toxin promotes mouse allergic skin disease by inducing mast cell degranulation , 2013, Nature.

[13]  J. Fierer,et al.  Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization , 2013, Cellular microbiology.

[14]  L. Aravind,et al.  A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta , 2013, The Journal of experimental medicine.

[15]  S. Abraham,et al.  Innate Immunity and Its Regulation by Mast Cells , 2013, The Journal of Immunology.

[16]  D. Voehringer Protective and pathological roles of mast cells and basophils , 2013, Nature Reviews Immunology.

[17]  D. Sheppard,et al.  The Role of Mast Cells in the Defence against Pathogens , 2012, PLoS pathogens.

[18]  M. Hickey,et al.  Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. , 2012, The American journal of pathology.

[19]  G. Reid,et al.  Importance of Vaginal Microbes in Reproductive Health , 2012, Reproductive Sciences.

[20]  R. Nibbs,et al.  Mast cells reside in myometrium and cervix, but are dispensable in mice for successful pregnancy and labor , 2012, Immunology and cell biology.

[21]  D. Golenbock,et al.  Activation of the NLRP3 Inflammasome by Group B Streptococci , 2012, The Journal of Immunology.

[22]  C. Chen,et al.  Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. , 2011, Blood.

[23]  W. Tao,et al.  Serine/Threonine Phosphatase Stp1 Mediates Post-transcriptional Regulation of Hemolysin, Autolysis, and Virulence of Group B Streptococcus* , 2011, The Journal of Biological Chemistry.

[24]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[25]  Susan M. Schlenner,et al.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. , 2011, The Journal of clinical investigation.

[26]  F. Menzies,et al.  The role of mast cells and their mediators in reproduction, pregnancy and labour. , 2011, Human reproduction update.

[27]  C. Chen,et al.  The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis. , 2011, The American journal of pathology.

[28]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  H. Karasuyama,et al.  Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. , 2010, The Journal of clinical investigation.

[30]  M. Tsai,et al.  Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity , 2010, European journal of immunology.

[31]  C. Renken,et al.  Regulation of CovR expression in Group B Streptococcus impacts blood–brain barrier penetration , 2010, Molecular microbiology.

[32]  C. Rubens,et al.  Global report on preterm birth and stillbirth (2 of 7): discovery science , 2010, BMC pregnancy and childbirth.

[33]  J. Lawn,et al.  Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data , 2010, BMC pregnancy and childbirth.

[34]  B. Ryffel,et al.  Histamine Plays an Essential Regulatory Role in Lung Inflammation and Protective Immunity in the Acute Phase of Mycobacterium tuberculosis Infection , 2009, Infection and Immunity.

[35]  G. Grandi,et al.  CsrRS Regulates Group B Streptococcus Virulence Gene Expression in Response to Environmental pH: a New Perspective on Vaccine Development , 2009, Journal of bacteriology.

[36]  L. Kenney,et al.  Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR , 2009, Molecular microbiology.

[37]  K. Puopolo Epidemiology of Neonatal Early-onset Sepsis , 2008 .

[38]  A. Di Nardo,et al.  Mast Cell Cathelicidin Antimicrobial Peptide Prevents Invasive Group A Streptococcus Infection of the Skin1 , 2008, The Journal of Immunology.

[39]  K. Roget,et al.  Peritoneal Cell-Derived Mast Cells: An In Vitro Model of Mature Serosal-Type Mouse Mast Cells1 , 2007, The Journal of Immunology.

[40]  T. Midoro-Horiuti,et al.  Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. , 2007, Molecular immunology.

[41]  C. Rubens,et al.  Regulation of cytotoxin expression by converging eukaryotic‐type and two‐component signalling mechanisms in Streptococcus agalactiae , 2006, Molecular microbiology.

[42]  D. Kasper,et al.  Regulation of Virulence by a Two-Component System in Group B Streptococcus , 2005, Journal of bacteriology.

[43]  M. Vergassola,et al.  CovS/CovR of group B streptococcus: a two‐component global regulatory system involved in virulence , 2004, Molecular microbiology.

[44]  R. Berner Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period , 2004, Expert review of anti-infective therapy.

[45]  F. Gantner,et al.  Critical Role of Histamine H4 Receptor in Leukotriene B4 Production and Mast Cell-Dependent Neutrophil Recruitment Induced by Zymosan in Vivo , 2003, Journal of Pharmacology and Experimental Therapeutics.

[46]  S. Akira,et al.  Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. , 2002, The Journal of clinical investigation.

[47]  D. Whitaker‐Menezes,et al.  Structural diversity of mast cell granules in black and white skin , 2001, The British journal of dermatology.

[48]  V. Nizet,et al.  Genetic basis for the β‐haemolytic/cytolytic activity of group B Streptococcus , 2001, Molecular microbiology.

[49]  A. Jones,et al.  Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature‐tagged mutagenesis , 2000, Molecular microbiology.

[50]  J. Hauth,et al.  Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.

[51]  M. Overpeck,et al.  Racial Differences in the Patterns of Singleton Preterm Delivery in the 1988 National Maternal and Infant Health Survey , 1999, Maternal and Child Health Journal.

[52]  Y. Ohizumi,et al.  Characterization of mastoparan-induced histamine release from RBL-2H3 cells. , 1998, Toxicon : official journal of the International Society on Toxinology.

[53]  F. Braet,et al.  Drying cells for SEM, AFM and TEM by hexamethyldisilazane: a study on hepatic endothelial cells , 1997, Journal of microscopy.

[54]  G. Pendl,et al.  Effects of phosphatidylinositol-3-kinase inhibitors on degranulation and gene induction in allergically triggered mouse mast cells. , 1997, International archives of allergy and immunology.

[55]  R. Gibson,et al.  Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells , 1996, Infection and immunity.

[56]  D. Woolley,et al.  Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. , 1995, Biology of reproduction.

[57]  G. J. van der Vusse,et al.  Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells: roles of cytosolic calcium and protein tyrosine kinases. , 1995, Biochimica et biophysica acta.

[58]  Majeed Sk Mast cell distribution in mice. , 1994 .

[59]  M. Aridor,et al.  Activation of exocytosis by the heterotrimeric G protein Gi3. , 1993, Science.

[60]  S. Shinoda,et al.  Interaction of wasp venom mastoparan with biomembranes. , 1990, Biochimica et biophysica acta.

[61]  J. White,et al.  Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[62]  I. Sawaragi,et al.  Association of mast cells with vaginal trichomoniasis in endocervical smears. , 1983, Acta cytologica.

[63]  C. Kitada,et al.  A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. , 1979, Chemical & pharmaceutical bulletin.

[64]  M. Mccarty,et al.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens , 1975, The Journal of experimental medicine.

[65]  R. G. Eagon,et al.  Type-Specific Antigens of Group B Type Ic Streptococci , 1971, Infection and immunity.

[66]  M. Bertini,et al.  Probiotics in the prevention of recurrences of bacterial vaginosis. , 2014, Alternative therapies in health and medicine.

[67]  D. Golenbock,et al.  Activation of the NLRP 3 Inflammasome by Group B Streptococci , 2012 .

[68]  Tsuyoshi Inoue,et al.  Comparative study of the membrane-permeabilizing activities of mastoparans and related histamine-releasing agents in bacteria, erythrocytes, and mast cells. , 2011, Biochimica et biophysica acta.

[69]  S. Schrag,et al.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[70]  T. Midoro-Horiuti,et al.  Estradiol activates mast cells via a non-genomic estrogen receptor- α and calcium influx , 2008 .

[71]  R. H. Albert,et al.  Prevention of Perinatal Group B Streptococcal Disease , 2007 .

[72]  Discovery Science , 2002, Lecture Notes in Computer Science.

[73]  J. Michel Preterm singleton births--United States, 1989-1996. , 1999, MMWR. Morbidity and mortality weekly report.

[74]  S. K. Majeed Mast cell distribution in mice. , 1994, Arzneimittel-Forschung.

[75]  T. Martin,et al.  Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. , 1988, The Journal of infectious diseases.